Kimberly Snyder, Marshall Shaffer, Aprajita Dhundia, Matt Suhosky, Vivek Ratnam, Mike Beinus
January 24, 2026
Kirkland Advises EW Healthcare on Partnership with Ascend Advanced Therapies

1 min
AI-made summary
- Kirkland & Ellis represented EW Healthcare Partners in a partnership with Ascend Advanced Therapies, a gene-to-GMP development company, aimed at expanding Ascend's presence and capabilities in the United States
- As part of the transaction, EW Healthcare Partners sold its portfolio company, Advanced BioScience Laboratories, to Ascend and made a significant capital investment in Ascend to support its continued growth
- The Kirkland team included both corporate and tax lawyers.
Kirkland & Ellis advised EW Healthcare Partners on a partnership with Ascend Advanced Therapies (Ascend), a gene-to-GMP development company, which will help to expand the footprint and capabilities of Ascend in the United States. As part of the broader transaction, EW Healthcare Partners also sold its portfolio company, Advanced BioScience Laboratories (ABL), a biotherapy, oncolytic and viral vector contract development, and manufacturing organization (CDMO) located in Rockville, Md., to Ascend and made a significant capital investment in Ascend in order to support the continued growth of the company. Read the transaction press release The Kirkland team included corporate lawyers Kimberly Snyder, Marshall Shaffer, Aprajita Dhundia and Matt Suhosky and tax lawyers Vivek Ratnam and Mike Beinus.
Article Author
Kimberly Snyder, Marshall Shaffer, Aprajita Dhundia, Matt Suhosky, Vivek Ratnam, Mike Beinus
The Sponsor
